期刊文献+

枸橼酸咖啡因与氨茶碱治疗早产儿原发性呼吸暂停疗效对比分析 被引量:1

下载PDF
导出
摘要 探究枸橼酸咖啡因与氨茶碱治疗早产儿原发性呼吸暂停(AOP)效果及其用药安全性分析。选取2014年4月~2016年7月收治的60例原发性AOP早产儿为观察对象,按照随机数字表法将早产儿分为对照组和观察组,每组30例。对照组患儿则在常规治疗的基础上给予氨茶碱治疗:首剂5mg/kg静脉注射,12h后给予维持量2mg/(kg·次),Bid,静脉注射,当原发呼吸暂停消失5d后停药。观察组患儿常规治疗的基础上给予枸橼酸咖啡因治疗,首剂20mg/kg静脉注射,24h后给予维持量5mg/kg/d,qd,静脉注射,当原发AOP消失5d后停药。对比两组疗效及不良反应发生情况。观察组早产儿治疗总有效率为90.00%,与对照组(治疗总有效率73.33%)相当((Z=2.794,P>0.05)),其药物不良反应发生率(6.67%)与对照组(43.33%)比较明显低,差异有统计学意义(P>0.05)。枸橼酸咖啡因治疗原发性AOP的疗效显著,安全性高,应作为治疗原发性AOP的首选药物。
出处 《现代诊断与治疗》 CAS 2017年第6期1062-1064,共3页 Modern Diagnosis and Treatment
  • 相关文献

参考文献4

二级参考文献36

  • 1Aranda JV, Beharry K, Valencia GB, et al. Caffeine impact on neonatal morbidities. J Matern Fetal Neonatal Med, 2010, 23: 20-23.
  • 2Picone S,Bedetta M, Paolillo P how long. A literature review. 2012, 25: 11-14.
  • 3Caffeine citrate: when and for J Matem Fetal Neonatal Med, Natarajan G, Botica ML, Aranda JV. Pharmacology Review Clinical pharmacology of caffeine in the newborn. NeoReviews 2007, 8:214-221.
  • 4Mayer CA, Haxhiu MA, Martin RJ, et al. Adenosine A2A receptors mediate GABAergic inhibition of respiration in immature rats. J Appl Physiol (1985), 2006, 100: 91-97.
  • 5Wilson CG, Martin RJ, Jaber M, et al. Adenosine A2A receptors interact with GABAergic pathways to modulate respiration in neonatal piglets. Respir Physiol Neurobiol, 2004, 141: 201- 211.
  • 6Kumral A, Tuzun F, Yesilirmak DC, et al. Genetic basis of apnoea of prematurity and caffeine treatment response: role of adenosine receptor polymorphisms: genetic basis of apnoea of prematurity. Acta Paediatr, 2012, 101 : e299-303.
  • 7Kot M, Daniel WA. The relative contribution of human cytochrome P450 isoforms to the four caffeine oxidation pathways : an in vitro comparative study with cDNA-expressed P450s including CYP2C isoforms. Biochem Pharmacol, 2008,76 : 543- 551.
  • 8Leon AE, Michienzi K, Ma CX, et al. Serum caffeine concentrations in preterm neonates. Am J Perinatol, 2007, 24: 39-47.
  • 9Charles BG, Townsend SR, Steer PA, et al. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring. Ther Drug Monit, 2008, 30: 709- 716.
  • 10Steer PA, Flenady V J, Shearman A, et al. Periextubation caffeine in preterm neonates: a randomized dose response trial. JPaediatr Child Health, 2003, 39: 511-515.

共引文献144

同被引文献7

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部